Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Insulin Aspart”

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT01486381
What this trial is testing

Long Term Safety of Biphasic Insulin Aspart 30 in Juveniles With Type 1 Diabetes

Who this might be right for
DiabetesDiabetes Mellitus, Type 1
Novo Nordisk A/S 22
Not applicableStudy completedNCT00696163
What this trial is testing

Observational Study to Assess the Quality of Life and Clinical Outcomes in Subjects Using NovoMix® 30 for the Treatment of Diabetes

Who this might be right for
DiabetesDiabetes Mellitus, Type 2
Novo Nordisk A/S 24,975
Post-approval studies (Phase 4)UnknownNCT04772729
What this trial is testing

Does the Use of Fiasp vs. Asp Lead to the Prolonged TIR in Children With Type 1 Diabetes?

Who this might be right for
Diabetes type1Diabetes Mellitus, Type 1
Medical University of Warsaw 77
Not applicableStudy completedNCT01039532
What this trial is testing

Comparison of Thrice Daily Biphasic Human Insulin With Basal Bolus Regimen in Type 2 Diabetes Mellitus Patients

Who this might be right for
Diabetes Mellitus, Type 2
Post Graduate Institute of Medical Education and Research, Chandigarh 50
Post-approval studies (Phase 4)Study completedNCT01427920
What this trial is testing

Comparison of Biphasic Insulin Aspart 30 Individually Adjusted by the Subject and the Trial Physician, Both Combined With Metformin in Subjects With Type 2 Diabetes

Who this might be right for
DiabetesDiabetes Mellitus, Type 2
Novo Nordisk A/S 348
Not applicableStudy completedNCT00709683
What this trial is testing

Observational Study to Evaluate the Safety of NovoMix® 30 FlexPen®

Who this might be right for
DiabetesDiabetes Mellitus, Type 2
Novo Nordisk A/S 216
Not applicableUnknownNCT04965051
What this trial is testing

Safety and Efficacy of Insulin Degludec/Insulin Aspart in Patients With T1DM

Who this might be right for
Type 1 Diabetes Mellitus With Diabetic GastroparesisHbA1cTime in Range
Second Affiliated Hospital, Zhejiang University, School of Medicine 40
Large-scale testing (Phase 3)Study completedNCT01520753
What this trial is testing

Comparison of Two Biphasic Insulin Aspart Treatments in Subjects With Type 2 Diabetes

Who this might be right for
DiabetesDiabetes Mellitus, Type 2
Novo Nordisk A/S 16
Post-approval studies (Phase 4)Study completedNCT02582242
What this trial is testing

Comparing Efficacy and Safety of Thrice Daily Versus Twice Daily NovoMix® 30 (Biphasic Insulin Aspart 30) in Subjects With Type 2 Diabetes Inadequately Controlled With Basal Insulin

Who this might be right for
DiabetesType 2 Diabetes Mellitus
Novo Nordisk A/S 437
Large-scale testing (Phase 3)Study completedNCT00065130
What this trial is testing

Safety and Efficacy of Insulin Aspart vs. Regular Human Insulin in Gestational Diabetes

Who this might be right for
DiabetesGestational Diabetes
Novo Nordisk A/S 27
Large-scale testing (Phase 3)Study completedNCT02491528
What this trial is testing

A Phase III Study of Insulin Aspart Injection to Evaluate the Efficacy and Safety

Who this might be right for
Diabetes
Tonghua Dongbao Pharmaceutical Co.,Ltd 563
Testing effectiveness (Phase 2)WithdrawnNCT03335501
What this trial is testing

Comparison of the Efficacy of Rapid-acting Aspart and Faster Acting Aspart Within the Context of Single-hormone Closed-loop Strategy at Regulating Postprandial Glucose Levels

Who this might be right for
Type 1 Diabetes Mellitus
Institut de Recherches Cliniques de Montreal
Not applicableStudy completedNCT05199714
What this trial is testing

A Fully-closed Loop, Pramlintide and Insulin, Artificial Pancreas Clinical Trial for Adults With Type 1 Diabetes

Who this might be right for
Type 1 Diabetes
McGill University Health Centre/Research Institute of the McGill University Health Centre 12
Early research (Phase 1)Study completedNCT01536028
What this trial is testing

Comparison of the Pharmacodynamics and Pharmacokinetics of Biphasic Insulin Aspart 30, 50, 70 and Insulin Aspart in Subjects With Type 1 Diabetes

Who this might be right for
DiabetesDiabetes Mellitus, Type 1
Novo Nordisk A/S 32
Post-approval studies (Phase 4)Study completedNCT00600366
What this trial is testing

Efficacy and Safety of Biphasic Insulin Aspart 30 FlexPen® in Insulin Naive Subjects With Type 2 Diabetes

Who this might be right for
DiabetesDiabetes Mellitus, Type 2
Novo Nordisk A/S 71
Large-scale testing (Phase 3)Study completedNCT01650129
What this trial is testing

Safety and Efficacy of Biphasic Insulin Aspart 50 in Subjects With Type 2 Diabetes

Who this might be right for
DiabetesDiabetes Mellitus, Type 2
Novo Nordisk A/S 83
Large-scale testing (Phase 3)Study completedNCT00623194
What this trial is testing

Safety Follow-up on Children and Adolescents With Type 1 Diabetes Treated With Insulin Detemir. An Extension to Trial NN304-1689

Who this might be right for
DiabetesDiabetes Mellitus, Type 1
Novo Nordisk A/S 146
Not applicableStudy completedNCT05417841
What this trial is testing

Safety and Efficacy of Insulin Degludec/Insulin Aspart in Patients With T2DM

Who this might be right for
Type 2 Diabetes Mellitus
Beijing Hospital 218
Early research (Phase 1)Study completedNCT01527643
What this trial is testing

Bioequivalence of Two Formulations of Biphasic Insulin Aspart 50 in Healthy Subjects

Who this might be right for
DiabetesHealthy
Novo Nordisk A/S 30
Large-scale testing (Phase 3)Study completedNCT01831765
What this trial is testing

Efficacy and Safety of FIAsp Compared to Insulin Aspart Both in Combination With Insulin Detemir in Adults With Type 1 Diabetes

Who this might be right for
DiabetesDiabetes Mellitus, Type 1
Novo Nordisk A/S 1,290
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation